Numinus CEO Payton Nyquvest shares why 2023 will be the year for breakthrough research in the psychedelic space and outlines how exactly the industry will benefit from it.

He also explains how the industry is evolving based on the recent news in Alberta on becoming the first Canadian province to regulate psychedelic drugs for therapeutic use, along with the upcoming midterms in Colorado where voters will have a say in the legalization of psychedelic drugs

Educating you on Stocks, Web3, and the Business of Cannabis & Psychedelics! Subscribe

---

Hosted on Acast. See acast.com/privacy for more information.